ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Author:

,Baigent Colin,Windecker Stephan,Andreini Daniele,Arbelo Elena,Barbato Emanuele,Bartorelli Antonio L,Baumbach Andreas,Behr Elijah R,Berti Sergio,Bueno Héctor,Capodanno Davide,Cappato Riccardo,Chieffo Alaide,Collet Jean-Philippe,Cuisset Thomas,de Simone Giovanni,Delgado Victoria,Dendale Paul,Dudek Dariusz,Edvardsen Thor,Elvan Arif,González-Juanatey José R,Gori Mauro,Grobbee Diederick,Guzik Tomasz J,Halvorsen Sigrun,Haude Michael,Heidbuchel Hein,Hindricks Gerhard,Ibanez Borja,Karam Nicole,Katus Hugo,Klok Fredrikus A,Konstantinides Stavros V,Landmesser Ulf,Leclercq Christophe,Leonardi Sergio,Lettino Maddalena,Marenzi Giancarlo,Mauri Josepa,Metra Marco,Morici Nuccia,Mueller Christian,Petronio Anna Sonia,Polovina Marija M,Potpara Tatjana,Praz Fabien,Prendergast Bernard,Prescott Eva,Price Susanna,Pruszczyk Piotr,Rodríguez-Leor Oriol,Roffi Marco,Romaguera Rafael,Rosenkranz Stephan,Sarkozy Andrea,Scherrenberg Martijn,Seferovic Petar,Senni Michele,Spera Francesco R,Stefanini Giulio,Thiele Holger,Tomasoni Daniela,Torracca Luccia,Touyz Rhian M,Wilde Arthur A,Williams Bryan

Abstract

Abstract Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19. Methods and results A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19. Conclusion This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3